MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%
OKUR — OnKure Therapeutics, Inc. Class A Common Stock
NasdaqOnKure Therapeutics, Inc. Class A Common Stock
$2.35
-0.11(-4.47%)
- O
- 2.41
- H
- 2.46
- L
- 2.30
- V
- 260.72K
⏱️ End-of-day dataAs of Oct 7, 2026
Chart
About OKUR
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateOct 7, 2024
Employees45
Stock ExchangeNasdaq
Ticker SymbolOKUR
Key Financial Statistics
| Market Cap | $103.67M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $2.23 - $5.38 |
| 52-Week Avg Volume | 232.1K |
| VWAP | $2.39 |
| Transactions | 2,135 |
| Total Recorded Bars | 1,382 days |